Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction

被引：0

作者：

Markus Menges

Thomas Hoehler

机构：

[1] Diakonie-Klinikum gGmbH,Department of Internal Medicine

[2] Prosper-Hospital,Medical Department I

来源：

Journal of Cancer Research and Clinical Oncology | 2009年 / 135卷

关键词：

Gastric cancer; Gastroesophageal junction cancer; Systemic therapy; Neoadjuvant chemotherapy; Adjuvant radiochemotherapy; Palliative chemotherapy; New chemotherapeutic agents;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Gastric cancer is a major health issue and a leading cause of death worldwide. The results of standard therapy remain unsatisfactory mainly because of diagnosis at the late stage of disease. Innovative strategies such as neoadjuvant chemotherapy in locally advanced cancer have improved the outcome even in operable cases. Whether an adjuvant radiochemotherapy is of benefit after curative resection including systematic lymphadenectomy remains yet unclear. Some progress has been made in the palliative setting by introducing new substances. This review examines recent advances in the systemic treatment of gastric and gastroesophageal junction cancer.

引用

页码：29 / 38

页数：9

共 50 条

[1] Current strategies in systemic treatment of gastric cancer and cancer of the gastroesophageal junction
Menges, Markus
Hoehler, Thomas
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (01) : 29 - 38
[2] Neoadjuvant Treatment Strategies for Resectable Proximal Gastric, Gastroesophageal Junction and Distal Esophageal Cancer
Ahmad, M. Usman
Javadi, Christopher
Poultsides, George A.
CANCERS, 2022, 14 (07)
[3] Gastroesophageal junction cancer - current topic and treatment dilemmas
Milosevic, Nikola
Stojanovic-Rundic, Suzana
Milanovic, Srdan
Keramatollah, Ebrahim
Sabljak, Predrag
Skrobic, Ognjan
Bjelovic, Milos
SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2024, 152 (7-8) : 419 - 423
[4] The current landscape of gastric cancer and gastroesophageal junction cancer diagnosis and treatment in China: a comprehensive nationwide cohort analysis
Yang Chen
Keren Jia
Yi Xie
Jiajia Yuan
Dan Liu
Lei Jiang
Haoxin Peng
Jia Zhong
Jian Li
Xiaotian Zhang
Lin Shen
Journal of Hematology & Oncology, 18 (1)
[5] Application of molecular targeted therapies for treatment of gastric cancer and gastroesophageal junction cancer
Czyzykowski, Rafal
Polowinczak-Przybylek, Joanna
Janiak, Anna
Frackowiak, Marta
Potemski, Piotr
ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 (05): : 244 - 252
[6] Emerging strategies in the treatment of advanced esophageal, gastroesophageal junction, and gastric cancer: the introduction of targeted therapies
T. Macarulla
C. Valverde
F. J. Ramos
E. Casado
E. Martinelli
J. Tabernero
A. Cervantes
Targeted Oncology, 2006, 1 : 23 - 33
[7] Emerging strategies in the treatment of advanced esophageal, gastroesophageal junction, and gastric cancer: the introduction of targeted therapies
Macarulla, T.
Valverde, C.
Ramos, F. J.
Casado, E.
Martinelli, E.
Cervantes, A.
Tabernero, J.
TARGETED ONCOLOGY, 2006, 1 (01) : 23 - 33
[8] Angiogenesis inhibitors in gastric and gastroesophageal junction cancer
Giandomenico Roviello
Roberto Petrioli
Luigi Marano
Karol Polom
Daniele Marrelli
Armando Perrella
Franco Roviello
Gastric Cancer, 2016, 19 : 31 - 41
[9] Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
Zhening Zhang
Tong Xie
Xiaotian Zhang
Changsong Qi
Lin Shen
Zhi Peng
Chinese Journal of Cancer Research, 2020, 32 (03) : 287 - 302
[10] Immune checkpoint inhibitors for treatment of advanced gastric or gastroesophageal junction cancer: Current evidence and future perspectives
Zhang, Zhening
Xie, Tong
Zhang, Xiaotian
Qi, Changsong
Shen, Lin
Peng, Zhi
CHINESE JOURNAL OF CANCER RESEARCH, 2020, 32 (03) : 287 - 302

← 1 2 3 4 5 →